Department of Obstetrics and Gynaecology, PEDEGO Research Unit, Medical Research Center, Oulu University Hospital, University of Oulu, Oulu, Finland.
Department of Pathology, Oulu University Hospital, University of Oulu, Oulu, Finland.
Pathol Oncol Res. 2021 Sep 28;27:1609936. doi: 10.3389/pore.2021.1609936. eCollection 2021.
Stanniocalcin-1 (STC-1) is a glycoprotein hormone involved in diverse biological processes, including regulation of calcium phosphate homeostasis, cell proliferation, apoptosis, inflammation, oxidative stress responses, and cancer development. The role of STC-1 in endometrial cancer (EC) is yet to be elucidated. In this study, we investigated the protein expression pattern of STC-1 in a tissue microarray (TMA) cohort of hysterectomy specimens from 832 patients with EC. We then evaluated the prognostic value of STC-1 expression regarding the clinicopathologic features and patients survival over a period of 140 months. Our results revealed that in EC tissue samples, STC-1 is mainly localized in the endometrial epithelium, although some expression was also observed in the stroma. Decreased STC-1 expression was associated with factors relating to a worse prognosis, such as grade 3 endometrioid tumors ( = 0.030), deep myometrial invasion ( = 0.003), lymphovascular space invasion ( = 0.050), and large tumor size ( = 0.001). Moreover, STC-1 expression was decreased in tumors obtained from obese women ( = 0.014) and in women with diabetes mellitus type 2 (DMT2; = 0.001). Interestingly, the data also showed an association between DNA mismatch repair (MMR) deficiency and weak STC-1 expression, specifically in the endometrial epithelium ( = 0.048). No association was observed between STC-1 expression and disease-specific survival. As STC-1 expression was particularly low in cases with obesity and DMT2 in the TMA cohort, we also evaluated the correlation between metformin use and STC-1 expression in an additional EC cohort that only included women with DMT2 (n = 111). The analysis showed no difference in STC-1 expression in either the epithelium or the stroma in women undergoing metformin therapy compared to metformin non-users. Overall, our data may suggest a favorable role for STC-1 in EC behavior; however, further studies are required to elucidate the detailed mechanism and possible applications to cancer treatment.
斯钙素 1(STC-1)是一种糖蛋白激素,参与多种生物学过程,包括钙磷稳态调节、细胞增殖、凋亡、炎症、氧化应激反应和癌症发展。STC-1 在子宫内膜癌(EC)中的作用尚未阐明。在这项研究中,我们使用组织微阵列(TMA)队列对 832 例 EC 子宫切除标本进行了 STC-1 蛋白表达模式的研究。然后,我们评估了 STC-1 表达与临床病理特征以及患者 140 个月生存的相关性。我们的结果表明,在 EC 组织样本中,STC-1 主要定位于子宫内膜上皮,尽管在基质中也有一些表达。STC-1 表达降低与预后较差的因素有关,如 3 级子宫内膜样肿瘤(=0.030)、深肌层浸润(=0.003)、血管淋巴管侵犯(=0.050)和大肿瘤体积(=0.001)。此外,肥胖女性(=0.014)和 2 型糖尿病(DMT2;=0.001)患者的肿瘤中 STC-1 表达降低。有趣的是,数据还显示 DNA 错配修复(MMR)缺陷与弱 STC-1 表达之间存在关联,特别是在子宫内膜上皮(=0.048)。STC-1 表达与疾病特异性生存无关。由于 TMA 队列中肥胖和 DMT2 患者的 STC-1 表达特别低,我们还在仅包括 DMT2 女性的另一组 EC 队列中评估了二甲双胍的使用与 STC-1 表达之间的相关性(n=111)。结果显示,与二甲双胍非使用者相比,接受二甲双胍治疗的女性在上皮和基质中 STC-1 表达均无差异。总的来说,我们的数据可能表明 STC-1 在 EC 行为中具有有利作用;然而,需要进一步的研究来阐明其详细机制和可能在癌症治疗中的应用。